Published in Medical Letter on the CDC and FDA, February 22nd, 2004
These earnings were up 44% from the $0.16 reported a year ago. Total revenues for the second quarter increased 30% to $13.7 million compared to $10.5 million in the prior year period.
Net sales increased 26% to $8.0 million from $6.4 million in the comparable quarter of the prior fiscal year. Royalty income from Angio-Seal sales increased 42% to $5.6 million from $3.9 million. Net income for the quarter increased 54% to $2.8 million compared to $1.8 million for the prior-year period.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.